Korro Bio, Inc. (KRRO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
KRRO currently has 14.4M outstanding shares. with significant dilution risk as 29.2M authorized shares could dilute existing holders by 202.6%. The company has significantly diluted shareholders by 62.37% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 14.4M shares outstanding |
14M | 29M |
| Mar 13, 2026 |
S-3 filing: This prospectus relates to the proposed offer and resale or other disposition from time to time by the selling stockholders identified in this prospectus, or collectively the selling stockholders, of up to an aggregate of 7,650,764 shares of our common stock. |
14M | 29M |
| Mar 12, 2026 |
10-K filing | 14.4M shares outstanding |
14M | 22M |
| Mar 09, 2026 |
8-K filing: Korro Bio, Inc. entered into a subscription agreement to sell 4,501,928 shares of common stock at $11.11 per share and pre-funded warrants to acquire 3,148,836 shares of common stock at $11.109 per warrant in a private placement. ($85.09M proceeds) |
9.4M | 27M |
| Nov 12, 2025 |
10-Q filing | 9.4M shares outstanding |
9.4M | 27M |
| Aug 12, 2025 |
10-Q filing | 9.4M shares outstanding |
9.4M | 27M |
| May 07, 2025 |
10-Q filing | 9.4M shares outstanding |
9.4M | 27M |
| Mar 18, 2025 |
10-K filing | 8.9M shares outstanding |
8.9M | 27M |
| Dec 02, 2024 |
POS AM filing: This prospectus relates to the proposed offer and resale of up to 1,504,537 shares of common stock of Korro Bio, Inc. by selling stockholders. |
9.3M | 27M |
| Dec 02, 2024 |
S-3 filing: The company files an S-3 to register the offering of debt securities, common stock and preferred stock, with an aggregate value of $400,000,000. It also files for an ATM offering of common stock through TD Cowen, up to $100,000,000. |
9.3M | 27M |
| Dec 02, 2024 |
POS AM filing: This prospectus relates to the proposed offer and resale or other disposition from time to time by the selling stockholders identified in this prospectus of up to an aggregate of 1,213,569 shares of common stock, par value $0.001 per share, of Korro Bio, Inc. |
9.3M | 27M |
| Nov 12, 2024 |
10-Q filing | 9.3M shares outstanding |
9.3M | 28M |
| Aug 13, 2024 |
10-Q filing | 9.0M shares outstanding |
9M | 28M |
| May 14, 2024 |
10-Q filing | 9.3M shares outstanding |
9.3M | 28M |
| May 14, 2024 |
S-1 filing: This S-1 filing relates to the proposed offer and resale of up to 1,213,569 shares of common stock by selling stockholders. |
8M | 29M |
| Mar 26, 2024 |
POS AM filing: This POS AM filing registers the resale of up to 1,504,537 shares of common stock by selling stockholders of Korro Bio, Inc. |
37M | 0 |
| Mar 26, 2024 |
10-K filing | 8.0M shares outstanding |
8M | 28M |
| Dec 20, 2023 |
S-1/A filing: This S-1/A filing relates to the proposed offer and resale of up to 1,714,570 shares of common stock by selling stockholders of Korro Bio, Inc. |
37M | 790K |
| Dec 01, 2023 |
S-1/A filing: This S-1/A filing relates to the proposed offer and resale of up to 2,077,864 shares of common stock by selling stockholders of Korro Bio, Inc. |
37M | 1.2M |
| Nov 06, 2023 |
S-3 filing: This S-3 filing relates to the proposed offer and resale of up to 2,077,864 shares of common stock by selling stockholders of Korro Bio, Inc. |
37M | 1.2M |
| Nov 02, 2023 |
10-Q filing | 36.9M shares outstanding |
37M | 0 |
| Aug 10, 2023 |
10-Q filing | 36.5M shares outstanding |
37M | 0 |
| May 12, 2023 |
10-Q filing | 35.8M shares outstanding |
36M | 240K |
| Mar 10, 2023 |
10-K filing | 35.3M shares outstanding |
35M | 710K |
| Nov 08, 2022 |
10-Q filing | 35.3M shares outstanding |
35M | 730K |
| Aug 09, 2022 |
10-Q filing | 35.3M shares outstanding |
35M | 730K |
| May 04, 2022 |
10-Q filing | 35.0M shares outstanding |
35M | 1M |
| Mar 15, 2022 |
10-K filing | 35.0M shares outstanding |
35M | 1M |
| Nov 15, 2021 |
10-Q filing | 34.6M shares outstanding |
35M | 1.4M |
| Aug 12, 2021 |
10-Q filing | 34.4M shares outstanding |
34M | 1.6M |
| May 13, 2021 |
10-Q filing | 34.2M shares outstanding |
34M | 1.8M |
| Mar 29, 2021 |
10-K filing | 34.2M shares outstanding |
34M | 1.8M |
| Nov 16, 2020 |
S-3 filing: Frequency Therapeutics, Inc. is filing an S-3 to offer and sell up to $300 million in the aggregate of common stock, preferred stock, and debt securities from time to time in one or more offerings. |
34M | 2.4M |
| Nov 16, 2020 |
10-Q filing | 33.7M shares outstanding |
34M | 2.3M |
| Aug 28, 2020 |
S-1 filing: This prospectus relates to the resale of up to 2,350,108 shares of common stock by the selling stockholders. The company will not receive any proceeds from the sale of the shares. |
34M | 2.4M |
| Aug 12, 2020 |
10-Q filing | 33.6M shares outstanding |
34M | 0 |
| May 14, 2020 |
10-Q filing | 31.0M shares outstanding |
31M | 0 |
| Mar 26, 2020 |
10-K filing | 30.9M shares outstanding |
31M | 0 |